ProCell Competitors

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Receptos, a wholly-owned subsidiary of Celgene. Please follow Celgene on LinkedIn. https://www.linkedin.com/company/celgene/

CBR is the world's largest cord blood and cord tissue bank. Cord Blood is rich in Stem Cells that are unique to the newborn and family. Cryopreservation of the cells has been called a type of 'biological insurance' because the stem cells are then available for use in medical treatments involving cancers and blood and immune disorders. The stem cells are an exact match for the newborn and have a higher likelihood of use in siblings. Diseases treated include leukemia, lymphoma, aplastic anemia and more than 75 other conditions amenable to stem cell transplant. New directions with cord blood stem cells include regenerative medicine for cerebral palsy and hearing loss.